Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 29;29(1):40.
doi: 10.1186/1756-9966-29-40.

Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study

Vanessa F Bernardes  1 , Frederico O Gleber-Netto, Sílvia F Sousa, Tarcília A Silva, Maria Cássia F Aguiar
Affiliations

Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study

Vanessa F Bernardes et al. J Exp Clin Cancer Res. .

Abstract

Background: The erbB receptors and their ligands are involved in the pathogenesis and progression of oral squamous cell carcinoma (OSCC). Although EGFR and Her-2 are frequently overexpressed in OSCC, few studies evaluated these proteins in saliva and their association with the tumor, which may represent potential usefulness in a clinical setting.

Methods: The levels of EGFR, Her-2, and EGF were evaluated in saliva of 46 patients with OSCC before and after the surgical removal of the lesion, as well as in matched healthy controls. The relationship of salivary levels and EGFR and Her-2 immunoexpression in tumor samples with clinicopathological features was analyzed.

Results: EGFR and Her-2 salivary levels did not show difference between to pre-surgery and control groups, however, both demonstrated an increase after surgical removal of the tumor. No association was detectable among receptor salivary levels, tissue expression and clinicopathological features. EGF levels in pre-surgery group were significantly lower when compared to the control group.

Conclusions: EGFR and Her-2 were not considered to be valuable salivary tumor markers in OSCC, however, lower levels of EGF in saliva may suggest a higher susceptibility for OSCC development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunoexpression of EGFR and Her-2. a: positive immunoexpression of EGFR in OSCC (400×); b: negative expression of Her-2 in OSCC (400×).
Figure 2
Figure 2
Salivary levels of EGFR, Her-2 and EGF. a: Salivary levels with standard deviation of EGFR in the control and OSCC groups; b: salivary levels with standard deviation of Her -2 in the control and OSCC groups; c: salivary levels with standard deviation of EGF in the control and OSCC groups. OSCC: oral squamous cell carcinoma; Pre-S: pre-surgery; Post-S: post-surgery; *:OSCC vs. control group (p < 0.05); #: pre-surgery vs. post-surgery (p < 0.05).
See this image and copyright information in PMC

References

    1. Erman M. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras. J BUON. 2007;12(Suppl 1):S83–94. - PubMed
    1. McInnes C, Sykes BD. Growth factor receptors: structure, mechanism, and drug discovery. Biopolymers. 1997;43:339–366. doi: 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W. - DOI - PubMed
    1. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43:193–198. doi: 10.1016/j.oraloncology.2006.02.009. - DOI - PubMed
    1. Rautava J, Jee KJ, Miettinen PJ, Nagy B, Myllykangas S, Odell EW, Soukka T, Morgan PR, Heikinheimo K. ERBB receptors in developing, dysplastic and malignant oral epithelia. Oral Oncol. 2008;44:227–235. doi: 10.1016/j.oraloncology.2007.02.012. - DOI - PubMed
    1. Hoffmann TK, Ballo H, Braunstein S, Van Lierop A, Wagenmann M, Bier H. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck. Oral Oncol. 2001;37:50–56. doi: 10.1016/S1368-8375(00)00056-7. - DOI - PubMed

Publication types